Research graph
References from Thyroid function and psychosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Melatonin: An overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects
10.1007/s11011-012-9307-9 · 2012 · External reference
Myxoedematous madness
10.1136/bmj.2.4627.555 · 1949 · External reference
Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis
10.1016/j.psyneuen.2023.106049 · 2023 · External reference
Free thyroxine levels are associated with cognitive abilities in subjects with early psychosis
10.1016/j.schres.2015.04.030 · 2015 · External reference
Association between anti-thyroid antibodies and negative symptoms in early psychosis
10.1111/eip.12873 · 2020 · External reference
The thyroid-brain interaction in thyroid disorders and mood disorders
10.1111/j.1365-2826.2008.01774.x · 2008 · External reference
Thyroid hormones, serotonin and mood: Of synergy and significance in the adult brain
10.1038/sj.mp.4000963 · 2002 · External reference
The hypothalamic–pituitary–thyroid axis in patients with schizophrenia
10.1016/s0920-9964(99)00187-5 · 2000 · External reference
Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis
10.1016/j.neubiorev.2016.05.027 · 2016 · External reference
Thyroid hormone receptors in brain development and function
10.1038/ncpendmet0424 · 2007 · External reference
Thyroid adverse effects of psychotropic drugs
10.1097/wnf.0b013e31823429a7 · 2011 · External reference
Psychiatric manifestations of Graves’ hyperthyroidism: Pathophysiology and treatment options
10.2165/00023210-200620110-00003 · 2006 · External reference
Thyroid axis function after in-patient treatment of acute psychosis with antipsychotics: A naturalistic study
10.1186/s12888-014-0279-7 · 2014 · External reference
Blood concentrations of anterior pituitary hormones in drug-naïve people with first-episode psychosis: A systematic review and meta-analysis
10.1016/j.psyneuen.2023.106392 · 2023 · External reference
Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: Relationships with clinical phenotypes and cognitive deficits
10.1017/s0033291716001902 · 2016 · External reference
Cerebral blood flow and glucose metabolism in hypothyroidism: A positron emission tomography study
10.1210/jcem.86.8.7749 · 2001 · External reference
Effect of lithium carbonate on the function of the thyroid gland: Mechanism of action and clinical implications
2020 · External reference
Thyroid hormone and astroglia: Endocrine control of the neural environment
10.1111/jne.12283 · 2015 · External reference
Therapeutic use of melatonin in schizophrenia: A systematic review
10.5498/wjp.v11.i8.463 · 2021 · External reference
Neurocognitive aspects of hypothyroidism
10.1001/archinte.158.13.1413 · 1998 · External reference
Autoimmune diseases, bipolar disorder, and non-affective psychosis
10.1111/j.1399-5618.2010.00853.x · 2010 · External reference
Free thyroxine concentrations moderate the response to a cognitive remediation therapy in people with early psychosis: A pilot randomized clinical trial
10.3389/fpsyt.2020.00636 · 2020 · External reference
Association between thyroid autoimmunity and clinical characteristics in first-episode and drug-naive depressed patients with suicide attempts
10.1016/j.genhosppsych.2023.05.008 · 2023 · External reference
Hashimoto's encephalopathy: Epidemiologic data and pathogenetic considerations
10.1016/j.jns.2003.09.007 · 2004 · External reference
Cognitive deficits in schizophrenia: An updated metanalysis of the scientific evidence
10.1186/1471-244x-12-64 · 2012 · External reference
Treating cognitive impairment in schizophrenia with GLP-1RAs: An overview of their therapeutic potential
10.1080/13543784.2021.1951702 · 2021 · External reference
Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics
10.4088/jcp.v69n0717 · 2008 · External reference
Graves' disease and mental disorders
10.1016/j.jcte.2019.100207 · 2020 · External reference
Routine cerebrospinal fluid parameters as biomarkers in first-episode psychosis: A prospective observational study
10.1016/j.pnpbp.2021.110424 · 2022 · External reference
Association between free thyroxine levels and clinical phenotype in first-episode psychosis: A prospective observational study
10.7717/peerj.15347 · 2023 · External reference
Antipsychotics in hyperthyroid-related psychosis: Case report and systematic review
2018 · External reference
Alterations in monoamines level in discrete brain regions and other peripheral tissues in young and adult male rats during experimental hyperthyroidism
10.1016/j.ijdevneu.2013.03.003 · 2013 · External reference
The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia
10.1155/2012/540273 · 2012 · External reference
Death by unnatural causes, mainly suicide, is increased in patients with Hashimoto's thyroiditis. A nationwide Danish register study
10.1007/s12020-019-01946-5 · 2019 · External reference
Meta-analysis of blood cortisol levels in individuals with first-episode psychosis
10.1016/j.psyneuen.2019.03.014 · 2019 · External reference
Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia
10.1016/j.pnpbp.2012.06.008 · 2012 · External reference
Correlation analyse between thyroid hormone levels and severity of schizophrenia symptoms
10.5498/wjp.v15.i1.100880 · 2025 · External reference
Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment
10.1210/jc.2005-1775 · 2006 · External reference
Association between prolactin and thyroid hormones with severity of psychopathology and suicide risk in drug free male schizophrenia
10.1016/j.cca.2015.02.003 · 2015 · External reference
Effects of TSH, fT3 and fT4 levels on neurocognitive symptoms in patients with schizophrenia
10.17826/cumj.1135374 · 2022 · External reference
Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine
10.4088/jcp.v66n0111 · 2005 · External reference
Can quetiapine-induced hypothyroidism be reversible without quetiapine discontinuation?
10.1097/wnf.0b013e3181a8cbcc · 2009 · External reference
Clinical correlates of hypothalamic-pituitary-adrenal axis measures in individuals at risk for psychosis and with first-episode psychosis
10.1016/j.psychres.2018.05.018 · 2018 · External reference
Free thyroxine levels are associated with cognitive changes in individuals with a first episode of psychosis: A prospective 1-year follow-up study
10.1016/j.schres.2016.01.036 · 2016 · External reference
Sex-specific associations between sex hormones and clinical symptoms in late-life schizophrenia
10.1016/j.schres.2024.03.002 · 2024 · External reference
Schizophrenia—An overview
10.1001/jamapsychiatry.2019.3360 · 2020 · External reference
Adipocytokines and metabolic syndrome in patients with schizophrenia
10.3390/metabo10100410 · 2020 · External reference
Psychiatric presentations heralding hashimoto's encephalopathy: A systematic review and analysis of cases reported in literature
10.4103/jnrp.jnrp_440_16 · 2017 · External reference
Thyroid hormones in persons with schizophrenia: A systematic review and meta-analysis
10.1016/j.pnpbp.2021.110402 · 2021 · External reference
Myxedema psychosis: Systematic review and pooled analysis
2021 · External reference
Glycated haemoglobin is associated with poorer cognitive performance in patients with recent-onset psychosis
10.3389/fpsyt.2020.00455 · 2020 · External reference
Possible role of glial cells in the relationship between thyroid dysfunction and mental disorders
10.3389/fncel.2015.00194 · 2015 · External reference
Selected neuroendocrine factors as potential molecular biomarkers of early non-affective psychosis course in relation to treatment outcome: A pilot study
10.1016/j.heliyon.2023.e21173 · 2023 · External reference
Hashimoto's encephalopathy: A rare intricate syndrome
10.5812/ijem.4174 · 2012 · External reference
The association between first-episode psychosis and abnormal glycaemic control: Systematic review and meta-analysis
10.1016/s2215-0366(16)30262-0 · 2016 · External reference
The effects of novel and newly approved antipsychotics on serum prolactin levels: A comprehensive review
2014 · External reference
Metformin for neurocognitive dysfunction in schizophrenia: A systematic review
10.3389/fpsyt.2024.1540153 · 2025 · External reference
An exploration of blood-based biomarkers of negative symptoms of psychosis in men
10.1016/j.jpsychires.2024.06.050 · 2024 · External reference
Thyroid disease and cognition
10.1016/j.ecl.2014.02.006 · 2014 · External reference
A prospective 12-Week study of quetiapine in adolescents with schizophrenia spectrum disorders
10.1089/cap.2007.0048 · 2007 · External reference
Hashirnoto's encephalopathy
10.1212/wnl.41.2_part_1.228 · 1991 · External reference
The polygenic architecture of schizophrenia — Rethinking pathogenesis and nosology
10.1038/s41582-020-0364-0 · 2020 · External reference
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: A systematic review and narrative synthesis
10.1016/j.psyneuen.2018.04.012 · 2018 · External reference
Thyroid hormone levels in chronic schizophrenic patients: Association with psychopathology
2016 · External reference
Relationship between thyroid-stimulating hormone, BDNF levels, and hippocampal volume in antipsychotic-naïve first-episode psychosis patients
10.3389/fpsyt.2023.1301714 · 2023 · External reference
Association of insulin resistance with schizophrenia polygenic risk score and response to antipsychotic treatment
10.1001/jamapsychiatry.2019.0304 · 2019 · External reference
Targeting hormones for improving cognition in major mood disorders and schizophrenia: Thyroid hormones and prolactin
2019 · External reference
Neurological soft signs and thyroid hormones in schizophrenia spectrum disorders
10.1016/j.pnpbp.2025.111338 · 2025 · External reference
Use of thyroid hormone to diminish the cognitive side effects of psychiatric treatment
1997 · External reference
Free thyroxine and thyroid-stimulating hormone in severe mental disorders: A naturalistic study with focus on antipsychotic medication
10.1016/j.jpsychires.2018.09.014 · 2018 · External reference
Adipose tissue dysregulation at the onset of psychosis: Adipokines and social determinants of health
10.1016/j.psyneuen.2020.104915 · 2021 · External reference
Mental changes accompanying thyroid gland dysfunction
10.1001/archpsyc.1969.01740130050004 · 1969 · External reference
Neurocognitive aspects of hypothyroidism
10.1001/archinte.158.13.1413 · ExternalCitation · doi-reference
Mental changes accompanying thyroid gland dysfunction
10.1001/archpsyc.1969.01740130050004 · ExternalCitation · doi-reference
Association of insulin resistance with schizophrenia polygenic risk score and response to antipsychotic treatment
10.1001/jamapsychiatry.2019.0304 · ExternalCitation · doi-reference
Schizophrenia—An overview
10.1001/jamapsychiatry.2019.3360 · ExternalCitation · doi-reference
Melatonin: An overlooked factor in schizophrenia and in the inhibition of anti-psychotic side effects
10.1007/s11011-012-9307-9 · ExternalCitation · doi-reference
Death by unnatural causes, mainly suicide, is increased in patients with Hashimoto's thyroiditis. A nationwide Danish register study
10.1007/s12020-019-01946-5 · ExternalCitation · doi-reference
Association between prolactin and thyroid hormones with severity of psychopathology and suicide risk in drug free male schizophrenia
10.1016/j.cca.2015.02.003 · ExternalCitation · doi-reference
Thyroid disease and cognition
10.1016/j.ecl.2014.02.006 · ExternalCitation · doi-reference
Association between thyroid autoimmunity and clinical characteristics in first-episode and drug-naive depressed patients with suicide attempts
10.1016/j.genhosppsych.2023.05.008 · ExternalCitation · doi-reference
Selected neuroendocrine factors as potential molecular biomarkers of early non-affective psychosis course in relation to treatment outcome: A pilot study
10.1016/j.heliyon.2023.e21173 · ExternalCitation · doi-reference
Alterations in monoamines level in discrete brain regions and other peripheral tissues in young and adult male rats during experimental hyperthyroidism
10.1016/j.ijdevneu.2013.03.003 · ExternalCitation · doi-reference
Graves' disease and mental disorders
10.1016/j.jcte.2019.100207 · ExternalCitation · doi-reference
Hashimoto's encephalopathy: Epidemiologic data and pathogenetic considerations
10.1016/j.jns.2003.09.007 · ExternalCitation · doi-reference
Free thyroxine and thyroid-stimulating hormone in severe mental disorders: A naturalistic study with focus on antipsychotic medication
10.1016/j.jpsychires.2018.09.014 · ExternalCitation · doi-reference
An exploration of blood-based biomarkers of negative symptoms of psychosis in men
10.1016/j.jpsychires.2024.06.050 · ExternalCitation · doi-reference
Cortisol awakening response in patients with psychosis: Systematic review and meta-analysis
10.1016/j.neubiorev.2016.05.027 · ExternalCitation · doi-reference
Triiodothyronine may be possibly associated with better cognitive function and less extrapyramidal symptoms in chronic schizophrenia
10.1016/j.pnpbp.2012.06.008 · ExternalCitation · doi-reference
Thyroid hormones in persons with schizophrenia: A systematic review and meta-analysis
10.1016/j.pnpbp.2021.110402 · ExternalCitation · doi-reference
Routine cerebrospinal fluid parameters as biomarkers in first-episode psychosis: A prospective observational study
10.1016/j.pnpbp.2021.110424 · ExternalCitation · doi-reference
Neurological soft signs and thyroid hormones in schizophrenia spectrum disorders
10.1016/j.pnpbp.2025.111338 · ExternalCitation · doi-reference
Clinical correlates of hypothalamic-pituitary-adrenal axis measures in individuals at risk for psychosis and with first-episode psychosis
10.1016/j.psychres.2018.05.018 · ExternalCitation · doi-reference
Targeting hypothalamic-pituitary-adrenal axis hormones and sex steroids for improving cognition in major mood disorders and schizophrenia: A systematic review and narrative synthesis
10.1016/j.psyneuen.2018.04.012 · ExternalCitation · doi-reference
Meta-analysis of blood cortisol levels in individuals with first-episode psychosis
10.1016/j.psyneuen.2019.03.014 · ExternalCitation · doi-reference
Adipose tissue dysregulation at the onset of psychosis: Adipokines and social determinants of health
10.1016/j.psyneuen.2020.104915 · ExternalCitation · doi-reference
Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis
10.1016/j.psyneuen.2023.106049 · ExternalCitation · doi-reference
Blood concentrations of anterior pituitary hormones in drug-naïve people with first-episode psychosis: A systematic review and meta-analysis
10.1016/j.psyneuen.2023.106392 · ExternalCitation · doi-reference
Free thyroxine levels are associated with cognitive abilities in subjects with early psychosis
10.1016/j.schres.2015.04.030 · ExternalCitation · doi-reference
Free thyroxine levels are associated with cognitive changes in individuals with a first episode of psychosis: A prospective 1-year follow-up study
10.1016/j.schres.2016.01.036 · ExternalCitation · doi-reference
Sex-specific associations between sex hormones and clinical symptoms in late-life schizophrenia
10.1016/j.schres.2024.03.002 · ExternalCitation · doi-reference
The hypothalamic–pituitary–thyroid axis in patients with schizophrenia
10.1016/s0920-9964(99)00187-5 · ExternalCitation · doi-reference
The association between first-episode psychosis and abnormal glycaemic control: Systematic review and meta-analysis
10.1016/s2215-0366(16)30262-0 · ExternalCitation · doi-reference
Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: Relationships with clinical phenotypes and cognitive deficits
10.1017/s0033291716001902 · ExternalCitation · doi-reference
Thyroid hormone receptors in brain development and function
10.1038/ncpendmet0424 · ExternalCitation · doi-reference
The polygenic architecture of schizophrenia — Rethinking pathogenesis and nosology
10.1038/s41582-020-0364-0 · ExternalCitation · doi-reference
Thyroid hormones, serotonin and mood: Of synergy and significance in the adult brain
10.1038/sj.mp.4000963 · ExternalCitation · doi-reference
Treating cognitive impairment in schizophrenia with GLP-1RAs: An overview of their therapeutic potential
10.1080/13543784.2021.1951702 · ExternalCitation · doi-reference
A prospective 12-Week study of quetiapine in adolescents with schizophrenia spectrum disorders
10.1089/cap.2007.0048 · ExternalCitation · doi-reference
Can quetiapine-induced hypothyroidism be reversible without quetiapine discontinuation?
10.1097/wnf.0b013e3181a8cbcc · ExternalCitation · doi-reference
Thyroid adverse effects of psychotropic drugs
10.1097/wnf.0b013e31823429a7 · ExternalCitation · doi-reference
Association between anti-thyroid antibodies and negative symptoms in early psychosis
10.1111/eip.12873 · ExternalCitation · doi-reference
The thyroid-brain interaction in thyroid disorders and mood disorders
10.1111/j.1365-2826.2008.01774.x · ExternalCitation · doi-reference
Autoimmune diseases, bipolar disorder, and non-affective psychosis
10.1111/j.1399-5618.2010.00853.x · ExternalCitation · doi-reference
Thyroid hormone and astroglia: Endocrine control of the neural environment
10.1111/jne.12283 · ExternalCitation · doi-reference
Myxoedematous madness
10.1136/bmj.2.4627.555 · ExternalCitation · doi-reference
The role of oestrogen and other hormones in the pathophysiology and treatment of schizophrenia
10.1155/2012/540273 · ExternalCitation · doi-reference
Cognitive deficits in schizophrenia: An updated metanalysis of the scientific evidence
10.1186/1471-244x-12-64 · ExternalCitation · doi-reference
Thyroid axis function after in-patient treatment of acute psychosis with antipsychotics: A naturalistic study
10.1186/s12888-014-0279-7 · ExternalCitation · doi-reference
Neuropsychological function and symptoms in subjects with subclinical hypothyroidism and the effect of thyroxine treatment
10.1210/jc.2005-1775 · ExternalCitation · doi-reference
Cerebral blood flow and glucose metabolism in hypothyroidism: A positron emission tomography study
10.1210/jcem.86.8.7749 · ExternalCitation · doi-reference
Hashirnoto's encephalopathy
10.1212/wnl.41.2_part_1.228 · ExternalCitation · doi-reference
Effects of TSH, fT3 and fT4 levels on neurocognitive symptoms in patients with schizophrenia
10.17826/cumj.1135374 · ExternalCitation · doi-reference
Psychiatric manifestations of Graves’ hyperthyroidism: Pathophysiology and treatment options
10.2165/00023210-200620110-00003 · ExternalCitation · doi-reference
Possible role of glial cells in the relationship between thyroid dysfunction and mental disorders
10.3389/fncel.2015.00194 · ExternalCitation · doi-reference
Glycated haemoglobin is associated with poorer cognitive performance in patients with recent-onset psychosis
10.3389/fpsyt.2020.00455 · ExternalCitation · doi-reference
Free thyroxine concentrations moderate the response to a cognitive remediation therapy in people with early psychosis: A pilot randomized clinical trial
10.3389/fpsyt.2020.00636 · ExternalCitation · doi-reference
Relationship between thyroid-stimulating hormone, BDNF levels, and hippocampal volume in antipsychotic-naïve first-episode psychosis patients
10.3389/fpsyt.2023.1301714 · ExternalCitation · doi-reference
Metformin for neurocognitive dysfunction in schizophrenia: A systematic review
10.3389/fpsyt.2024.1540153 · ExternalCitation · doi-reference
Adipocytokines and metabolic syndrome in patients with schizophrenia
10.3390/metabo10100410 · ExternalCitation · doi-reference
Thyroid function in treatment-resistant schizophrenia patients treated with quetiapine, risperidone, or fluphenazine
10.4088/jcp.v66n0111 · ExternalCitation · doi-reference
Metabolic and hormonal side effects in children and adolescents treated with second-generation antipsychotics
10.4088/jcp.v69n0717 · ExternalCitation · doi-reference
Psychiatric presentations heralding hashimoto's encephalopathy: A systematic review and analysis of cases reported in literature
10.4103/jnrp.jnrp_440_16 · ExternalCitation · doi-reference
Therapeutic use of melatonin in schizophrenia: A systematic review
10.5498/wjp.v11.i8.463 · ExternalCitation · doi-reference
Correlation analyse between thyroid hormone levels and severity of schizophrenia symptoms
10.5498/wjp.v15.i1.100880 · ExternalCitation · doi-reference
Hashimoto's encephalopathy: A rare intricate syndrome
10.5812/ijem.4174 · ExternalCitation · doi-reference
Association between free thyroxine levels and clinical phenotype in first-episode psychosis: A prospective observational study
10.7717/peerj.15347 · ExternalCitation · doi-reference
